Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synthesis and uses thereof

Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synthesis and uses thereof

US Patent 10087175 · Granted Oct 2, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mesothelin-targeted trail trimer2024
Mesothelin-targeted trail trimer2024
Low affinity poly(AD-ribose) polymerase 1 dependent cytotoxic agents2023
Methods of diagnosing and treating cancer comprising ME12021
Radiolabeled and fluorescent PARP inhibitors for imaging and radiotherapy2021
Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synth2021
Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synth2021
Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synth2021
Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synth2021
Sigma-2 receptor ligand drug conjugates as antitumor compounds, methods of synth2021
Radiotracer derivatives of trimethoprim for diagnostic imaging2020
211-astatine containing radiotherapeutics for the treatment of cancer2019